ConMed Corp., a leading global supplier of arthroscopic devices, multi-specialty endoscopic medical video systems, and powered surgical instruments, faced several stiff challenges when it embarked on the development of the industry’s first UL-approved autoclavable battery.
In a draft guidance document, FDA has placed its summary of ideas regarding biocompatibility and possible changes that could eventually replace FDA G-95 Blue Book Memorandum #G95-1 on biocompatibility. The draft document has been out since April and is widely available, though it has not been formally released.
European Launch of New Version of Codman Neuro’s Revive SE Thrombectomy Device for Treatment of Acute Ischemic StrokeSeptember 9, 2013 2:06 pm | by Codman Neuro | News | Comments
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the European launch of the REVIVE™ SE Thrombectomy Device, a next generation clot removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke.
Once-rejected CardioMEMs will get another shot at FDA approval for its Champion implantable heart failure monitoring systems when the agency's Circulatory System Devices Panel convenes next month, according to a notice in the Federal Register.
Researchers in Vienna develop new imaging technique to study the function of entire nervous systems Scientists at the Campus Vienna Biocenter have found a way to overcome some of the limitations of light microscopy. Applying the new technique, they can record the activity of a worm’s brain with high temporal and spatial resolution, ultimately linking brain anatomy to brain function.
Collecting samples of exhaled breath from people at a high risk of lung cancer could be a cheap and non-invasive method of diagnosing the disease, according to new research. The findings will be presented today at the European Respiratory Society (ERS) Annual Congress in Barcelona.
A team of scientists at Karolinska Institutet and Harvard University has taken a major step towards treatment for heart attack, by instructing the injured heart in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.
A team of researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University has found a way to self-assemble complex structures out of bricks smaller than a grain of salt. The self-assembly method could help solve one of the major challenges in tissue engineering...
Researchers at a university in eastern Zhejiang Province have used a 3D printer to create living kidneys, which is expected to be used for transplants in the future.
Disease-causing bacteria stink — literally — and the odor released by some of the nastiest microbes has become the basis for a faster and simpler new way to diagnose blood infections and finger the specific microbe. The new test produces ...
Medical technology company iSonea Limited has announced that testing and technical documentation has been completed for the AirSonea Wheeze Monitor to receive the Conformité Européenne or CE Mark.
The KineSpring System is designed to be a first surgical option for patients with knee osteoarthritis (OA). It is intended to treat the symptoms of pain and loss of knee function secondary to OA of the medial compartment of the knee.
University of Utah electrical engineers have developed a network of wireless sensors that can detect a person falling. This monitoring technology could be linked to a service that would call emergency help for the elderly without requiring them to wear monitoring devices. For people age 65 and older, falling ...
Intelomed, Inc., a developer of noninvasive medical devices and technology for monitoring cardiovascular stability, today announced it has secured $4 million in funding from new and existing shareholders through the sale of its Series A-1 Common Preferred stock.
Guided Therapeutics, Inc. today announced that the company received additional questions from the U.S. Food and Drug Administration (FDA) regarding the pre-market approval application for the LuViva ® Advanced Cervical Scan. FDA advised the company the PMA was not yet approvable in its current form and that the company needed to address these questions in order to place the PMA in approvable form.